Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Henney Insider Profile
4 Followers
Christopher Henney, Director at Anthera Pharmaceuticals, holds 39.41K shares in Cyclacel Pharmaceuticals (Ticker: CYCC), holds 0.00 shares in Prothena (Ticker: PRTA), holds 0.00 shares in Cascadian Therapeutics (Ticker: CASC).
Christopher Henney Anthera Pharmaceuticals (ANTH)Director
Anthera Pharmaceuticals (ANTH)
Director
Ranked #85,974 out of 98,624 Corporate Insiders
Profitable Transactions
1 out of 14 Profitable Transactions
Average Return
-16.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Christopher Henney holds in companies
Most Profitable Insider Trade
Stock:
Cascadian Therapeutics
(CASC)
(CASC)
Rating:Informative Buy
Date:Feb 01, 2017 - Feb 01, 2018
Return:+136.50%
The most profitable trade made by Christopher Henney
Christopher Henney's Trading History
Anthera Pharmaceuticals
Jul 02, 2012
Director
Informative Buy
148.00K
$9.07K
Cascadian Therapeutics
Mar 13, 2018
―
Uninformative Sell
―
$0.00
Cyclacel Pharmaceuticals
Jul 03, 2023
Director
Uninformative Buy
―
$59.52K
Prothena
Jul 16, 2021
Director
Informative Buy
125.85K
$0.00
Sarepta Therapeutics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Christopher Henney's performance on stock
You May Also Like
Christopher Henney insider profile FAQ
What is the percentage of profitable transactions made by Christopher Henney?
The percentage of profitable transactions made by Christopher Henney is 7%.
What is the average return per transaction made by Christopher Henney?
The average return per transaction made by Christopher Henney is -16.60%.
What stocks does Christopher Henney hold?
Christopher Henney holds: ANTH, CASC, CYCC, PRTA, SRPT stocks.
What was Christopher Henney’s latest transaction?
Christopher Henney latest transaction was an Uninformative Buy of ―.
What was Christopher Henney's most profitable transaction?
Christopher Henney’s most profitable transaction was an Informative Buy of CASC stock on February 1, 2017. The return on the trade was 136.50%.
What is Christopher Henney's role in Anthera Pharmaceuticals?
Christopher Henney's role in Anthera Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.